Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Loews Sapphire Falls Resort

Mar 18, 2019 11:00 AM - Mar 20, 2019 1:30 PM

6601 Adventure Way,, Orlando, FL 32819

Medical Affairs and Scientific Communications Forum

3 Meetings, 1 Location: Medical Communications, Medical Science Liaisons, Medical Writing

Session 7 Track 1A: The Three D’s of RWE

Session Chair(s)

Ellen  Whipple, PharmD

Ellen Whipple, PharmD

Owner/Principal Writer

EW Associates, LLC, United States

Donna  Booth, PharmD

Donna Booth, PharmD

Head, Field Medical Accounts-East, US Medical Affairs

GlaxoSmithKline, United States

Real-world data (RWD) and real world evidence (RWE) play an increasing role in healthcare decisions. RWD is derived from multiple sources outside typical clinical research settings, including electronic health records (EHRs), claims and billing data, product and disease registries, and data gathered through personal devices and health applications. RWE is the intersection between the structured rigor of a randomized control trial and the clinical exposure a treatment receives once it enters clinical practice as it is derived from analysis of RWD. Medical information departments vary in their understanding and approach to the 3 D’s (definition, decision makers, and dissemination) of RWE. As the US healthcare system continues to seek value for patients, it is increasingly important to have strategies for addressing RWE across the continuum of decision makers (regulators, payers, HCPs and patients).

Learning Objective :
  • Define RWE by discussing various types and differentiating from clinical trial data
  • Recognize decision makers receiving RWE and describe how RWE brings value based on their unique perspectives
  • Propose strategies for dissemination of RWE by sharing examples utilized by various medical information departments that demonstrated success as well as areas for improvement
  • Share strategies from audience members regarding dissemination of RWE

Speaker(s)

Fred  Cox, PhD

Real World Evidence: Therapeutic Effectiveness Beyond Efficacy

Fred Cox, PhD

Cox Econometric Research, LLC, United States

President and Principal of CERES

Dawn  Beach, PharmD

Sharing the Value of RWE

Dawn Beach, PharmD

GlaxoSmithKline, United States

Medical Information Director, Respiratory US Medical Information

Chirayu  Parikh, PharmD

Digital Dissemination of RWE: EvidenceFinder

Chirayu Parikh, PharmD

Novo Nordisk Inc., United States

Regional Medical Liaison

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.